Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A pilot study in the swine model of lethal cyanide intoxication indicates efficacy of a platinum-methionine complex countermeasure.

Scientific reports·2026
Same author

Flow-mediated endothelial remodeling and inflammation drive developmental vascular susceptibility in ldlr loss of function.

Nature communications·2026
Same author

Optimizing single-lead ECG axis for AI-based detection of myocardial diseases.

NPJ cardiovascular health·2026
Same author

Mitochondrial dysfunction underlies cardiac contractility and growth defects in a zebrafish model of <i>NAA15</i>-related heart disease.

bioRxiv : the preprint server for biology·2026
Same author

Beyond Glycogen Storage: AMPKγ2 Regulates Cardiac Hypertrophy and Electrophysiology via Myosin Interaction.

bioRxiv : the preprint server for biology·2026
Same author

Only Economic Solutions Will Enable the Implementation of Genetic Sequencing in the Real World.

Journal of evaluation in clinical practice·2026
Same journal

Extracellular Vesicles in Hemostasis.

Clinics in laboratory medicine·2026
Same journal

Thrombin Generation Assay: Ready for Prime Time.

Clinics in laboratory medicine·2026
Same journal

Viscoelastic Testing for the Laboratorian: Recent Advances and Practical Advice.

Clinics in laboratory medicine·2026
Same journal

Practical Recommendations for Harmonization of Hemostasis Testing Across Hospital Sites.

Clinics in laboratory medicine·2026
Same journal

The Role of Hypoxia in Vascular Endothelial Dysfunction and Venous Thromboembolism.

Clinics in laboratory medicine·2026
Same journal

Updates in Antiphospholipid Syndrome Laboratory Diagnosis.

Clinics in laboratory medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 8, 2026

FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

Clinical screening and genetic testing.

Rahul C Deo1, Calum A MacRae

  • 1Cardiology Division, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA.

Clinics in Laboratory Medicine
|September 14, 2010
PubMed
Summary
This summary is machine-generated.

Effective clinical screening for genetic diseases requires understanding genetic architecture. This approach aids early diagnosis of cardiomyopathies and inherited conditions, even before symptoms appear.

More Related Videos

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016

Related Experiment Videos

Last Updated: Jun 8, 2026

FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016

Area of Science:

  • Genetics
  • Cardiology
  • Medical Diagnostics

Background:

  • Clinical screening is most effective for diseases diagnosed early, often before symptoms manifest.
  • Inexpensive, noninvasive diagnostic tests are crucial for effective screening programs.
  • Genetic disease architecture plays a key role in determining screening feasibility.

Purpose of the Study:

  • To discuss general principles of genetic disease architecture.
  • To guide screening and diagnostic approaches for cardiomyopathies and inherited diseases.
  • To address how genetic architecture and clinical characteristics influence screening.

Main Methods:

  • Review of general principles of genetic disease architecture.
  • Analysis of how genetic traits influence screening strategies.
  • Evaluation of clinical characteristics impacting disease diagnosis.

Main Results:

  • Genetic architecture provides a framework for developing effective screening protocols.
  • Understanding disease presentation guides the selection of appropriate diagnostic tools.
  • Screening is optimized when genetic factors and clinical signs are considered together.

Conclusions:

  • Genetic disease architecture is fundamental to designing efficient screening and diagnostic strategies.
  • Early detection of cardiomyopathies and inherited diseases can be enhanced through tailored screening approaches.
  • Integrating genetic insights with clinical observations improves diagnostic accuracy and patient outcomes.